A meta-analysis and systemic review from @DrAnuraagJ, found JAK inhibitors to be "promising and effective options" for patients with acute severe #UlcerativeColitis as adjunct therapy to corticosteroids and rescue therapy. #ASUC#Gastroenterology#IBD
https://t.co/3IiWAMNIsV
Dr Elliot Tapper (@ebtapper) from @MichiganLiver shares some innovative potential treatment options for #BileAcidDiarrhea - and the joys that come from clinical investigation. #Gastroenterology
🌟 Read the full article here:
https://t.co/46k8q0atCi
Patients with #InflammatoryBowelDisease have an increased risk of psychiatric disorder from 2-3 years before diagnosis through 10 years after, highlighting the need for integration of psych. care into #IBD management. #Gastroenterology
🌟Read the article:
https://t.co/P37jbiKRUv
An investigational liver-targeted glucagon/GLP-1 dual agonist reduced liver fat compared with placebo among patients with #MASLD and #MASH.
@NoureddinMD of @MethodistHosp, said these results support further evaluation of DD01 in long-term studies.
https://t.co/pfO73HVE2E
Jeffrey Hyams, MD, discusses #ustekinumab for pediatric patients with #UlcerativeColitis who had conventional therapies. With the UNIFI JR results, ustekinumab may be "a very attractive therapy" for these patients.
📹 Watch the full interview here:
https://t.co/IVawgtVgvo
Corey Siegel, MD, from @GeiselMed, discusses the #RADIUSProgram which pairs a large specialty care center with small community-based practices to ensure no patient with #IBD falls through the cracks. #Gastroenterology
📹 Watch the full interview here:
https://t.co/D88iDtb6xz
Don't miss Dr Elliot Tapper's (@ebtapper) review of "The Liver Doctor" by Dr Cyriac Abby Phillips (@theliverdoc). Dr Tapper calls this book, "both a compelling work of medical narrative and a quiet act of advocacy." #Hepatology
Read the full review here:
https://t.co/DkbaBxsDed
Christopher Ma, MD, of University of Calgary, discusses results evaluating #EP104GI, an injectable formulation of the steroid fluticasone, for treatment of #EosinophilicEsophagitis. #Gastroenterology
📹 Watch the full interview here:
https://t.co/EKfHTfz2b7
Kathleen Ferrell, PA-C, MPAS, from UNC Chapel Hill discusses the important role a #PhysicianAssistant plays when diagnosing, treating, and managing patients with #EosinophilicEsophagitis. #Gastroenterology
📹 Get the APP Perspective in the full interview:
https://t.co/L5OUxnIwpS
We spoke with Dhyanesh Patel, MD, of @VUMCDiscoveries, about a study evaluating the ability of a mucosal integrity testing device to identify #EoE during an endoscope procedure. #EosinophilicEsophagitis
📹 Watch the full interview here:
https://t.co/mXPAyGwzef
In the duplicate phase 3 B-Well trials, bepirovirsen led to a functional cure among patients with chronic #HepatitisBVirus who discontinued nucleoside or nucleotide analogue (NA) therapy. #HBV#Hepatology
https://t.co/o7QJ61EKVL
At #DDW2026, we got an update to the...controversial #NordICC trial. Michael Bretthauer spoke to us about the data, concluding, "Screening or not, it doesn't do much for your death risk, but that risk is very, very low."
📹 Watch the full interview:
https://t.co/OEZEzob4GT